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A B S T R A C T   
Mycobacterial membrane protein Large (MmpL7) is a Resistance-Nodulation-Division (RND) family transporter 
required for the export of the virulence lipid, phthiocerol dimycocerosate (PDIM), in Mycobacterium tuberculosis. 
Using a null mutant of the related, vaccine strain Mycobacterium bovis BCG, we show that MmpL7 is also involved 
in the transport of the structurally related phenolic glycolipid (PGL), which is also produced by the hypervirulent 
M. tuberculosis strain HN878, but absent in M. tuberculosis H37Rv. Furthermore, we generated an in silico model of 
M. tuberculosis MmpL7 that revealed MmpL7 as a functional outlier within the MmpL-family, missing a canonical 
proton-relay signature sequence, suggesting that it employs a yet-unidentified mechanism for energy coupling for 
transport. In addition, our analysis demonstrates that the periplasmic porter domain 2 insert (PD2-insert), which 
doesn’t share any recognisable homology, is highly alpha-helical in nature, suggesting an organisation similar to 
that seen in the hopanoid PD3/4 domains. Using the M. bovis BCG mmpL7 mutant for functional complemen-
tation with mutated alleles of mmpL7, we were able to identify residues present in the transmembrane domains 
TM4 and TM10, and the PD2 domain insert that play a crucial role in PDIM transport, and in certain cases, 
biosynthesis of PDIM.   
Introduction 
The cell envelopes of mycobacteria, including the tuberculosis- 
causing Mycobacterium tuberculosis, are rich in unique lipids that form 
a hydrophobic barrier, playing a role in resistance and virulence (Jan-
kute et al., 2015; Gago et al., 2018; Garcia-Vilanova et al., 2019). 
Two M. tuberculosis cell envelope lipids, phthiocerol dimycocerosate 
(PDIM) and phenolic glycolipid (PGL) play an important role in viru-
lence. PDIM and PGL share a common structural core, a diol backbone 
(phthiocerol), esterified with two methyl-branched fatty-acyl moieties 
(dimycocerosates) (Onwueme et al., 2005) (Fig. 1). Genes required for 
the biosynthesis of this core are present in a cluster that includes five 
Type-I polyketide synthases, PpsA-E, which synthesise phthiocerol. 
Additionally, a Type-I fatty acid synthase termed mycocerosic acid 
synthase (Mas) produces mycocerosic acid (Onwueme et al., 2005) that 
is eventually esterified to phthiocerol. The structure of PGL builds on 
this common lipidic core, further expanded by a phenolic group, and 
glycosylation (Constant et al., 2002; Jackson et al., 2021; Perez et al., 
2004). The polyketide synthase Pks15/1 and a p-hydroxybenzoyl-AMP- 
ligase (FadD22) catalyse the formation of long-chain p- 
hydroxyphenylalkanoate intermediates that primes the synthesis of 
PGLs (Fig. 1). The M. tuberculosis strain H37Rv has a frameshift mutation 
in pks15/1 resulting in a deficiency in PGL production (Constant et al., 
2002; Reed et al., 2004) 
PDIM has been shown to be required at different stages of infection 
and mutants deficient in PDIM biosynthesis or transport are attenuated 
in animal models of infection (Camacho et al., 2001; Cox et al., 1999; 
Rens et al., 2021). PGLs are associated with the hypervirulence of select 
M. tuberculosis strains such as those from the W-Beijing family (Constant 
et al., 2002; Reed et al., 2004). The critical role of these PDIMs and PGLs 
in virulence and immunomodulation, warrants a detailed study of how 
they are made, and subsequently exported to the outer envelope of 
mycobacteria. 
Transport proteins termed Mycobacterial Membrane Protein Large 
(MmpL), are involved in the translocation of mycobacterial lipids across 
the plasma membrane (Chalut, 2016; Jackson et al., 2021). MmpLs are 
members of the Resistance-Nodulation-Division (RND) family of mem-
brane proteins, that are thought to be powered by proton motive force 
(PMF) and are distinguished by a common architecture consisting of 12 
transmembrane (TM) spanning regions and 2 porter domains (PD1 and 
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PD2) formed out of large periplasmic loops located between TM1/2 and 
TM7/8 respectively (Jackson et al., 2021). 
In M. tuberculosis the mmpL7 (Rv2942) gene is located in the PDIM/ 
PGL biosynthesis cluster (Onwueme et al., 2005) (Fig. 1). Null mutants 
of M. tuberculosis mmpL7 accumulate PDIM intracellularly (Camacho 
et al., 2001; Cox et al., 1999). Furthermore, the PD2 of M. tuberculosis 
MmpL7 has been shown to interact with the phthiocerol-producing 
PpsE, suggesting that biosynthesis of PDIM may be coupled with its 
transport (Jain and Cox, 2005). Other lipid-transporting MmpLs appear 
to function as stand-alone transporters, with no other genes in the 
biosynthesis cluster linked to transport (Bailo et al., 2015; Chalut, 2016). 
In contrast, MmpL7 appears to operate within a wider scaffold of 
translocator proteins. Mutants of M. tuberculosis lppX (encoding a lipo-
protein) and of the ABC-transporter drrABC, which is present in the same 
PDIM/PGL cluster, are also defective in PDIM-translocation, suggesting 
a complex and distinct transport mechanism, possibly driven by a 
multiple, interacting components (Camacho et al., 2001; Sulzenbacher 
et al., 2006). Also, uniquely, M. tuberculosis MmpL7 and its orthologues 
are the only MmpLs that do not possess conserved Asp/Tyr-residues 
located on the transmembrane helices 4/10 (TM4/TM10), critical for 
proton coupling of transport (Bernut et al., 2016; Chalut, 2016). 
Furthermore, while MmpL7 is known to transport PDIMs, its role in 
the transport of PGLs, which share a common structural core, remains to 
be studied in the M. tuberculosis complex, though the transport of PGLs in 
Mycobacterium marinum has been inferred to be linked to MmpL7 
(Cambier et al., 2014; Yu et al., 2012). Mycobacterium bovis BCG MmpL7 
shares 100% amino acid identity with M. tuberculosis MmpL7, and has an 
intact pks1/15 gene required for PGL-biosynthesis (Reed et al., 2004), 
allowing us to assess the role of MmpL7 in PGL-transport in slow 
growing mycobacteria. 
Additionally, we aimed to study structure–function relationships of 
M. tuberculosis MmpL7 by a combination of in silico and experimental 
approaches. We used a Mycobacterium bovis BCG mmpL7 null-mutant for 
complementation studies with mutant alleles of M. tuberculosis mmpL7, 
and to assess the impact of loss of mmpL7 on PGL transport. 
Results, materials and discussion 
We generated a M. bovis BCG mmpL7 null-mutant (ΔmmpL7) using 
Specialized Transduction (Bardarov et al., 2002; Larsen et al., 2007) and 
Fig. 1. (A) Structures of Phthiocerol dimycocerosate (PDIM) and phenolic glycolipid (PGL). Enzymes responsible for the biosynthesis of the p-hydrox-
yphenylalkanoate moiety of PGLs are indicated (B) Map of the PDIM/PGL biosynthesis and transport cluster in M. tuberculosis H37Rv. M. bovis BCG contains a single 
ORF representing pks1 and pks15. 
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labelled cultures of wild type (WT) strain and ΔmmpL7 mutant with 14C- 
propionate to selectively label methyl-branched fatty acid-containing 
lipids (including PDIMs and PGLs). Apolar lipids from spent media 
(exported lipids) and cell pellets (intracellular lipids) were extracted 
using standard methods (Dobson, 1985). Lipids were analysed by two- 
dimensional TLC systems A and C designed to visualise PDIMs and 
PGLs respectively (Dobson, 1985) (Fig. 2). As expected, the mutant 
showed loss of PDIM export and an intracellular accumulation of PDIMs 
(Fig. 2A) in agreement with the role of MmpL7 in M. tuberculosis 
(Camacho et al., 2001; Cox et al., 1999). A similar phenotype was 
observed for PGLs in the ΔmmpL7; PGL was not exported and accumu-
lated intracellularly, implying MmpL7 was involved in the shared 
transport of PDIMs and PGLs (Fig. 2B). To complement the M. bovis BCG 
ΔmmpL7 mutant, we cloned PCR-amplified mmpL7 downstream of the 
constitutive hsp60 promoter in the plasmid vector pMV261 (Stover et al., 
1991) to generate the complementing plasmid pMV261-mmpL7. Trans-
port of PDIMs was restored on transformation of ΔmmpL7 with pMV261- 
mmpL7 (Strain ΔmmpL7-C in Fig. 2A). Surprisingly, the complemented 
strain, which restored PDIM transport, showed a complete loss of PGLs. 
To account for the possibility that the overexpression of mmpL7 in the 
complemented strain abrogated PGL synthesis, mmpL7 was additionally 
cloned into the integrative vector pMV306 (Stover et al., 1991) under its 
native promoter to allow for generation of a separate complemented 
strain with a single copy and native expression patterns of mmpL7. This 
new strain, referred to as mmpL7-NC, showed a phenotype similar to that 
of ΔmmpL7-C, with PDIM-transport being restored, but PGL-biosynthesis 
being abolished (Fig. 2A, B). 
To probe this further, we sequenced the two complemented strains. 
No mutations were observed in PDIM-biosynthesis genes, however both 
complemented strains harboured a mutation in fadD22 which, as 
mentioned above, encodes a p-hydroxybenzoyl-AMP-ligase that primes 
PGL biosynthesis (Simeone et al., 2010). Accumulation of PGLs intra-
cellularly could be toxic in the long term (prolonged subculture and 
selection) and the fadD22 mutation likely represents a compensatory 
mutation. 
To identify and study functional domains, we generated a homology 
model of MmpL7 using the I-TASSER server (Yang et al., 2015), using 
structurally characterised RND-transporters, the E.coli AcrB (Johnson 
et al., 2020; Nakashima et al., 2011; Seeger et al., 2006) and 
M. smegmatis MmpL3 (Su et al., 2019; Zhang et al., 2019), as templates 
(Fig. 3A). As the latter is the closest relative of MmpL7 of known 
structure (See File S1, Supplementary Information for a multiple 
sequence alignment), with 14.7% identity, and 27% sequence similarity, 
we used it for primary homology modelling. It has to be noted that due 
to the low overall sequence similarity the predictive power of any such 
homology models is limited, so in addition, to avoid model bias and to 
compare the packing of the conserved TM-regions, we also used the AcrB 
as a reference RND-structure. 
In RND-permeases the energy required for substrate antiport is 
derived from proton-gradients stored across the inner membrane, which 
are channelled via conserved residues situated in TM4 and TM10 (Alav 
et al., 2021; Goldberg et al., 1999; Guan and Nakae, 2001), forming a 
proton-relay (Fig. 3B), which in MmpLs are represented by Asp/Tyr- 
pairs (Bernut et al., 2016; Park et al., 2015; Zhang et al., 2019). While 
the homology model of MmpL7 suggested that it shares most of its 
structural features with the other MmpLs (File S1, Supplementary Ma-
terial), superimpositions at conserved proton-relay sites revealed dif-
ferences. Namely, two Ala-residues (Ala287/288) are present on TM4, 
while Pro836/Tyr837 are found in place of the Asp-Tyr pair on TM10 
conserved in all other MmpLs (Fig. 3; Files S1 and S2, Supplementary 
Material) (Bernut et al., 2016; Chalut, 2016; Melly and Purdy, 2019). 
Furthermore, closer inspection of the sequence of MmpL7 did not reveal 
any Asp-Tyr or indeed any residue-pairs capable of forming a proton 
relay within its TM-domain. In the same TM10-helix, we identified 
another residue (Arg846) conserved across MmpL7-proteins from obli-
gate pathogens (File S2, Supplementary Material), not mentioned in 
previous works. Further analysis suggests that the majority of the resi-
dues forming the RND proton-relay network have no direct correspon-
dence in MmpL7. On the other hand, analysis of MmpL7 orthologues 
from PDIM-producing mycobacteria reveals conservation of TM4 
Ala287 and TM10 Pro836 (Fig. 3B). We targeted these residues to probe 
whether they contributed, in a yet unknown mechanism, to MmpL7 
activity (File S2, Supplementary Material). To that end, the replicative 
pMV261 complementing plasmid-derivative containing mmpL7, was 
used as a template for site-directed mutagenesis and mutated alleles 
were then transformed into the BCG ΔmmpL7-strain to test the ability to 
restore PDIM-transport. mmpL7 expression was confirmed in all trans-
formed strains by RT-PCR (File S3, Supplementary Material). Most of the 
mutated mmpL7-alleles were able to complement the null-mutant, 
restoring PDIM-transport, suggesting that these conserved residues 
were not critical for function (Fig. 4). Two separate mutations did affect 
the ability to restore PDIM-transport: the R846A substitution affected 
the ability to translocate PDIMs, while Y837F completely abolished 
PDIM-biosynthesis (Fig. 4). The loss of PDIM-biosynthesis in the latter is 
significant as whole genome sequencing did not reveal any mutations in 
PDIM-biosynthesis genes, indicating that the observed loss is due to the 
altered MmpL7. Thus, Y837 appears to play a wider-role, perhaps in 
coordinating PDIM-biosynthesis with transport. 
RND-transporters have a common structural blueprint shared across 
the family members, including MmpLs and are composed of several 
conserved modules (Alav et al., 2021). The TM4/TM10, which couple 
the proton-motive force with substrate efflux, transmit conformational 
Fig. 2. 2D TLC autoradiography of 
[14C]-propionate-labelled lipids from 
Wild type (WT), ΔmmpL7 mutant and 
two mmpL7 complemented strains 
(ΔmmpL7-C contains pMV261-mmpL7 
and ΔmmpL7-NC containing pMV306- 
mmpL7). Apolar lipid extracts from the 
culture filtrate (Out) and intracellular 
lipids (In) were separated using (A) sol-
vent systems A and (B) solvent system C 
(right). The three-pointed bracket shows 
the PDIM species, while the arrow de-
picts PGL. System A: direction 1, petro-
leum ether (60–80 ◦C): ethyl acetate, 
95:2 (v/v) X 3; direction 2, Petroleum 
ether (60–80 ◦C): acetone 92:8 (v/v). 
System C: direction 1, chloroform: 
methanol 96:4 (v/v), direction 2, 
Toluene: acetone, 80:20 (v/v).   
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changes to the periplasmic porter domains, which provide substrate- 
binding and dictate specificity (Su et al., 2019) and, in Gram-negative 
bacteria interact with adaptor proteins (Symmons et al., 2015) 
(Fig. 3A). These porter domains are themselves formed on a modular 
principle, based on a core module presenting a mixed α-β sandwich of a 
general (β1 − α1 − β2 − β3 − α2 − β4) configuration dubbed the PD- 
module (Alav et al., 2021). Each periplasmic loop of the MmpLs con-
tains a single PD-module, known as PD1 and PD2, for the N-terminal and 
C-terminal lobe of the transporter respectively (Chim et al., 2015; Zhang 
et al., 2019) (Fig. 5A). Consistent with that, comparative analysis be-
tween the MmpL7 homology-model and MmpL3 PD-domains revealed 
near identical PD1 shared between them, but a distinct PD2, which in 
the case of MmpL7 contains an additional structural motif, spliced be-
tween β2 − β3 strands (Fig. 5A). Further comparison with the AcrB PD- 
domains, reveals that while the PD1-domain of MmpL7 is similar to the 
contiguous AcrB PN1/PC1-domains, the PD2-domain presents an 
Fig. 3. (A) Comparison of the structural organisation of a typical RND-transporter (with the example of the E. coli AcrB; 2GIF.pdb), the MmpL3 transporter 
(experimental structure 6OR2.pdb, missing the C-terminal D3 domain), and MmpL7 (homology model, this study), highlighting the commonality of transmembrane 
(TM) domain assembly. Transmembrane helices TM4, TM6, TM10 and TM11 are coloured in deep blue, magenta, orange and green respectively. (B) Top-down view 
of a section of the TM-domain of the corresponding structures centred around the residues forming the proton-relays (AcrB, MmpL3), and the equivalent area in 
MmpL7, displaying lack of conservation and residues unsuitable to proton transfer. (For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
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insertion, at an equivalent position (namely between the respective β2 
− β3 strands) to the insertion of the FN (funnel or docking) sub-domains 
within the PN2/PC2 seen in the AcrB (Murakami et al., 2002). While the 
insertions are taking place at equivalent, conserved positions, which in 
the MmpL7 correspond to residues A472-T704 inclusive (Alav et al., 
2021), our analysis indicates that there is no similarity between the 
MmpL7 PD2-inserts and AcrB FN-domains (Fig. 3; Fig. 5A). Indeed, as 
indicated by a BLASTp search against the PDB-database, the MmpL7 
PD2 insert does not share recognisable homology with any known 
structures, but is predicted to be strongly alpha-helical in nature, 
possibly forming helical bundles, similar to the organisation of the 
hopanoid PD3/4 domains, which are inserted into the PD1 and PD2 of 
HpnN in an equivalent fashion (Alav et al., 2021; Kumar et al., 2017). 
In MmpL7 the PD2-domain has been identified as critical for 
recruitment of PpsE, the last polyketide synthase to produce phthio-
diolone in PDIM in M. tuberculosis (Fig. 1B) (Jain and Cox, 2005), sug-
gesting that the PD2-domains in MmpLs may be involved in 
protein–protein interactions. There are few lines of evidence that sup-
port this hypothesis. The lipid-binding lipoprotein LpqN, has been re-
ported to interact with the related MmpL3 and MmpL11 (Melly et al., 
2019), facilitating the passage of exported lipid to the outer envelope. 
Furthermore, LpqN-family proteins LpqT and Mtc28, as well as the non- 
homologous lipoprotein LprG (Rv1411c), interact with the MmpL11 
PD2-domain, but not the MmpL3 (Melly et al., 2019), with the latter 
being able to bind phosphatidylinositol-containing glycolipids and 
interact with the mycolyl transferase, Ag85A (Drage et al., 2010; Melly 
et al., 2019). Intriguingly, LprG and LppX belong to the same family of 
homologous lipid-binding lipoproteins, that in addition includes two 
lipoproteins of yet-unknown function, LprA and LprF. It is thus possible 
that LppX-MmpL7 interaction is similar to that observed between the 
LprG-MmpL11. 
These findings from previous work strongly suggest that the PD2- 
domains of MmpL proteins, and specifically their insertions, are likely 
focal points for scaffolding association of enzymatic machineries 
involved in the lipid-modification. Due to the lack of reliable structural 
template for the PD2-inserts, rational mutagenesis is problematic, but 
we probed several residues within MmpL7-PD2, conserved across 
MmpL7-orthologues (namely Asp524, Arg610, Ile611 and Asp670) 
(Fig. 4B) for functional effects. Additionally, we tested Asp673 and 
Glu676, which are found in the MmpL7-orthologues of obligatory 
pathogens and could likely have a bespoke role in this group of myco-
bacteria (Fig. 4B). 
All substitutions apart from R610D and D673A reinstated PDIM- 
transport (Fig. 4). However, the M. bovis BCG ΔmmpL7-strains car-
rying the D670R or E676A-substitutions showed complete loss of PDIM- 
biosynthesis, similar to what we observed in some of the above TM10- 
substitutions (e.g. Y837F). Notably both Ile611 and Asp673 were pre-
viously shown to be essential for the MmpL7-PpsE interaction (Jain and 
Cox, 2005). Similarly, whole-genome sequencing of the transformed 
strains did not reveal any mutations in PDIM-biosynthesis genes, 
Fig. 4. PDIM analysis of mmpL7 SDM mutants. TLC autoradiography of [14C]-propionate labelled lipids from Wild type (Wt), ΔmmpL7 mutant and thirteen mmpL7 
complemented strains. Amino acid substitutions (and position) are indicated between the two TLC plates. Apolar lipid extracts from the culture filtrate (Out) and 
intracellular lipids (In) were separated using petroleum ether: diethyl ether (9:1 v/v). An arrow shows the PDIM species. 
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Fig. 5. (A) Side view of the superposition of the 3D structures of the MmpL3 (cyan, based on 6OR2.pdb) and MmpL7 (homology model). Key domains in MmpL7 are 
coloured green (TM), blue (PD1) and red (PD2) respectively, with the PD2-insertion (indicated by the two red arrows) in salmon. Both PD1 and PD2 domains have a 
common architecture, with secondary structure elements being numbered. The analysis of the model reveals high general similarity of TM and periplasmic archi-
tecture between MmpL3 and MmpL7, with the exception of the large PD2-domain insertion, which is not present in MmpL3. (B) Multiple sequence alignment of the 
MmpL7 orthologues, visualised using Espript3, highlighting the predicted highly alpha-helical nature of the PD2-insertion and conservation of its residues across 
mycobacteria. The residues mutated in this study have been highlighted with red boxes. (For interpretation of the references to colour in this figure legend, the reader 
is referred to the web version of this article.) 
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suggesting a wider, yet-unidentified role for these residues. Consistent 
with the possible role of these residues in protein–protein interactions, 
within our I-TASSER model, the R610D and D637A map to the top of the 
helical PD2-insertion domain (File S4, panel A, Supplementary 
Material). 
While this work was under review, we gained access to the Alpha-
Fold v2.0 predictions (Jumper et al., 2021) for MmpL7 (https://alph 
afold.ebi.ac.uk/entry/P9WJU7; File S4, Supplementary Material). In 
contrast to traditional homology modelling, AlphaFold v.2.0 uses a 
contextual ab initio prediction minimising model bias. We anticipated 
this to be of particular benefit for the interpretation of the mutations 
within the PD2-insert of MmpL, which is hindered by the lack of reliable 
homology templates and based on the available structural data, our only 
reliable predictions were of high alpha-helical propensity of the insert. 
The PD2-insert of the AlphaFold model is consistent with our prediction, 
being fully alpha-helical and forming a helical bundle, but it has to be 
noted that it has also the lowest confidence prediction score within 
overall model, which limits its predictive power. While the overall 
conformation of the PD2-insert is markedly different, the locations of the 
phenotypically pronounced mutations are consistent with the PD2- 
domain playing a docking-platform for protein–protein interactions 
(File S4, panel A, Supplementary Material). Furthermore, encourag-
ingly, the results from AlphaFold v2.0, show close convergence with our 
earlier models within the TM and PD1/PD2 section of the protein with 
an RMSD of < 5 Å over Cα-backbone, excluding the PD2-insert. There 
are subtle, yet significant differences in the packing of TM10 and 11, 
with TM 11 packing tightly between TM4 and TM10, and segregating 
the conserved Tyr837 from its canonical partnering residues in TM4, 
further confirming that a canonical proton relay with the participation 
of the Tyr837 is not possible, which is consistent with our mutagenesis 
results (File S4, panel B, Supplementary Material). Intriguingly, this 
alternative conformation of the Tyr837 brings it in the vicinity of a 
cluster of charged residues located at the cytoplasmic end of TM11 
(Arg863) and TM (Gln909; Arg910), however future work would be 
required to elucidate the exact mechanism of energy coupling of 
MmpL7. 
In summary, our findings identify MmpL7 as a functional outlier 
within the MmpL-family, with a distinctive amino-acid signature with its 
TM-domain, suggesting a yet-unidentified mechanism for energy 
coupling. Furthermore, we have identified the alpha-helical PD2-insert 
domain of MmpL7 to be critical for its function. Given the role of other 
proteins in PDIM transport, it is likely that MmpL7 is part of a much 
larger complex for PDIM and PGL transport, likely providing a scaffold 
for co-ordinating transport with biosynthesis these virulence lipids. 
While the in silico model of MmpL7 used in this study is not without 
limitations, it helps to inform future structural and functional studies of 
this medically important protein. 
Declaration of Competing Interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
Acknowledgments 
NM was supported by a PhD studentship from the Darwin Trust of 
Edinburgh. AB acknowledges funding from the Medical Research 
Council (MR/K00042X/1 and MR/S000542/1). 
Data availability 
The authors declare that all relevant data supporting the findings of 
the study are available in this article and the Supplementary materials, 
or from the corresponding author upon reasonable request. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https://doi. 
org/10.1016/j.tcsw.2021.100062. 
References 
Alav, I., Kobylka, J., Kuth, M.S., Pos, K.M., Picard, M., Blair, J.M.A., Bavro, V.N., 2021. 
Structure, assembly, and function of tripartite efflux and type 1 secretion systems in 
gram-negative bacteria. Chem. Rev. 121, 5479–5596. 
Bailo, R., Bhatt, A., Ainsa, J.A., 2015. Lipid transport in Mycobacterium tuberculosis and 
its implications in virulence and drug development. Biochem. Pharmacol. 96, 
159–167. 
Bardarov, S., Bardarov, S., Pavelka, M.S., Sambandamurthy, V., Larsen, M., Tufariello, J., 
Chan, J., Hatfull, G., Jacobs, W.R., 2002. Specialized transduction: an efficient 
method for generating marked and unmarked targeted gene disruptions in 
Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148, 
3007–3017. 
Bernut, A., Viljoen, A., Dupont, C., Sapriel, G., Blaise, M., Bouchier, C., Brosch, R., de 
Chastellier, C., Herrmann, J.L., Kremer, L., 2016. Insights into the smooth-to-rough 
transitioning in Mycobacterium bolletii unravels a functional Tyr residue conserved 
in all mycobacterial MmpL family members. Mol. Microbiol. 99, 866–883. 
Camacho, L.R., Constant, P., Raynaud, C., Laneelle, M.A., Triccas, J.A., Gicquel, B., 
Daffe, M., Guilhot, C., 2001. Analysis of the phthiocerol dimycocerosate locus of 
Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall 
permeability barrier. J. Biol. Chem. 276, 19845–19854. 
Cambier, C.J., Takaki, K.K., Larson, R.P., Hernandez, R.E., Tobin, D.M., Urdahl, K.B., 
Cosma, C.L., Ramakrishnan, L., 2014. Mycobacteria manipulate macrophage 
recruitment through coordinated use of membrane lipids. Nature 505, 218–222. 
Chalut, N., 2016. MmpL transporter-mediated export of cell-wall associated lipids and 
siderophores in mycobacteria. Tuberculosis (Edinb) 100, 32–45. 
Chim, N., Torres, R., Liu, Y., Capri, J., Batot, G., Whitelegge, J.P., Goulding, C.W., 2015. 
The structure and interactions of periplasmic domains of crucial mmpl membrane 
proteins from mycobacterium tuberculosis. Chem. Biol. 22, 1098–1107. 
Constant, P., Perez, E., Malaga, W., Laneelle, M.A., Saurel, O., Daffe, M., Guilhot, C., 
2002. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the 
Mycobacterium tuberculosis complex. Evidence that all strains synthesize 
glycosylated p-hydroxybenzoic methyl esters and that strains devoid of 
phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J. Biol. Chem. 
277, 38148–38158. 
Cox, J. S., CHEN, B., MCNEIL, M. & JACOBS, W. R., JR. 1999. Complex lipid determines 
tissue-specific replication of Mycobacterium tuberculosis in mice. Nature, 402, 79- 
83. 
Dobson G, Minnikin D.E., Minnikin S.M., Parlett M., Goodfellow M. & M., R. 1985. 
Systematic analysis of complex mycobacterial lipids. Chemical Methods in Bacterial 
Systematics. . London: Academic Press. 
Drage, M.G., Tsai, H.C., Pecora, N.D., Cheng, T.Y., Arida, A.R., Shukla, S., Rojas, R.E., 
Seshadri, C., Moody, D.B., Boom, W.H., Sacchettini, J.C., Harding, C.V., 2010. 
Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid 
agonists of Toll-like receptor 2. Nat. Struct. Mol. Biol. 17, 1088–1095. 
Gago, G., Diacovich, L., Gramajo, H., 2018. Lipid metabolism and its implication in 
mycobacteria-host interaction. Curr Opin Microbiol 41, 36–42. 
Garcia-Vilanova, A., Chan, J., Torrelles, J.B., 2019. Underestimated manipulative roles of 
mycobacterium tuberculosis cell envelope glycolipids during infection. Front. 
Immunol. 10, 2909. 
Goldberg, M., Pribyl, T., Juhnke, S., Nies, D.H., 1999. Energetics and topology of CzcA, a 
cation/proton antiporter of the resistance-nodulation-cell division protein family. 
J. Biol. Chem. 274, 26065–26070. 
Guan, L., Nakae, T., 2001. Identification of essential charged residues in transmembrane 
segments of the multidrug transporter MexB of Pseudomonas aeruginosa. 
J. Bacteriol. 183, 1734–1739. 
Jackson, M., Stevens, C.M., Zhang, L., Zgurskaya, H.I., Niederweis, M., 2021. 
Transporters Involved in the biogenesis and functionalization of the mycobacterial 
cell envelope. Chem. Rev. 121, 5124–5157. 
Jain, M., Cox, J.S., 2005. Interaction between polyketide synthase and transporter 
suggests coupled synthesis and export of virulence lipid in M. tuberculosis. PLoS 
Pathog. 1, e2. 
Jankute, M., Cox, J.A., Harrison, J., Besra, G.S., 2015. Assembly of the mycobacterial cell 
wall. Annu. Rev. Microbiol. 69, 405–423. 
Johnson, R.M., Fais, C., Parmar, M., Cheruvara, H., Marshall, R.L., Hesketh, S.J., 
Feasey, M.C., Ruggerone, P., Vargiu, A.V., Postis, V.L.G., Muench, S.P., Bavro, V.N., 
2020. Cryo-EM structure and molecular dynamics analysis of the fluoroquinolone 
resistant mutant of the AcrB transporter from salmonella. Microorganisms 8. 
Jumper, John, Evans, Richard, Pritzel, Alexander, Green, Tim, Figurnov, Michael, 
Ronneberger, Olaf, Tunyasuvunakool, Kathryn, Bates, Russ, Žídek, Augustin, 
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